GFAP and Alzheimer disease: We demonstrated that the prediction accuracy for AD status by the combination of blood biomarkers, sex, APOE and PRS reaches AUC = 0.81 (R2 = 0.29) with the most significant contributors being APOE-ɛ4, Aβ40 and GFAP.